外科疾病导致的胆源性肝损伤诊治现状

doi:10.3969/j.issn.1672-5069.2021.06.002

实用肝脏病杂志 ›› 2021, Vol. 24 ›› Issue (6): 769-771.doi: 10.3969/j.issn.1672-5069.2021.06.002

外科疾病导致的胆源性肝损伤诊治现状

汤磊, 邹桂舟

230601 合肥市安徽医科大学第二附属医院感染病科/肝病科

收稿日期:2021-09-01 出版日期:2021-11-10 发布日期:2021-11-15
通讯作者: 邹桂舟,E-mail:ayzouguizhou@sina.com
作者简介:汤磊,男,33岁,硕士研究生,主治医师。主要从事慢性肝病的基础与临床研究。E-mail:tanglei@ahmu.edu.cn

Management of patients with biliary liver injury caused by surgical diseases

Tang Lei, Zou Guizhou

Department of Infectious Diseases and Liver Diseases, Second Affiliated Hospital, Anhui Medical University, Hefei 230601, Anhui Province, China

Received:2021-09-01 Online:2021-11-10 Published:2021-11-15

摘要/Abstract

关键词: 胆源性肝损伤, 胆石症, 胆道闭锁, 诊断, 治疗

Key words: Biliary liver injury, Surgical diseases, Diagnosis, Treatment

汤磊, 邹桂舟. 外科疾病导致的胆源性肝损伤诊治现状[J]. 实用肝脏病杂志, 2021, 24(6): 769-771.

Tang Lei, Zou Guizhou. Management of patients with biliary liver injury caused by surgical diseases[J]. Journal of Practical Hepatology, 2021, 24(6): 769-771.

[1] Virani S,Akers A,Stephenson K,et al. Comprehensive review of molecular mechanisms during cholestatic liver injury and cholangiocarcinoma. J Liver, 2018, 7(3): 321-325.
[2] Cai SY, Boyer JL. Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury. Inflamm Cell Signal, 2017,4(2):e1561.
[3] Woolbright BL. Inflammation: Cause or consequence of chronic cholestatic liver injury. Food Chem Toxicol,2020,137:111133.
[4] Videhult1 P, Sandblom G.Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy. Int Hepatopancreatobiliary Ass,2011,13,519-527.
[5] Cai SY, Ge M, Mennone A,et al. Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse. Cell Mol Gastroenterol Hepatol, 2020, 9(4):679-688.
[6] Rangaswamy R, Singh CG, Singh HM, et al. Impact of biliary calculi on the liver. J Clin Diagn Res, 2017,11(4):4-7.
[7] Lageron A, Levy VG, Saffroy M, et al. Histological and histoenzymological study of liver, in gallstone without treatment. Acta Histochem, 2009,65(1):1-7.
[8] Kakar S, Batts KP, Poterucha JJ, et al. Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment. J Clin Pathol, 2004,17(7):874-878.
[9] Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers, 2016,2:1-17.
[10] 黄志强. 医源性胆管狭窄:胆道外科之痛.中华消化外科杂志,2015,14(5):23-27.
[11] Geng ZM, Yao YM, Liu QG, et al. Mechanism of benign biliary stricture: a morphological and immunohistochemical study. World J Gastroenterol, 2005, (2):293-295.
[12] Li K, Shi C, Huang J, et al. Dexamethasone effect on the expression of transforming growth factor-β1/Smads signaling pathway in benign biliary stricture fibroblasts in rodent. J Coll Physicians Surg Pak,2017,27(3):131-134.
[13] 王敬. 胆道损伤及损伤性胆管狭窄的外科治疗见解. 中国医刊,2019,54(7):702-704.
[14] Mercado MA, Sanchez N, Urencio M. Major hepatectomy for the treatment of complex bile duct injury. Ann Surg, 2009,249(3):542-543.
[15] Negi SS, Chaudhary A. Analysis of abnormal recovery pattern of liver function tests after surgical repair of bile duct strictures. J Gastroenterol Hepatol, 2005,20(10):1533-1537.
[16] Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet,2009,374: 1704-1713.
[17] Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol, 2015,12(6):342-352.
[18] A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, et al. Is biliary atresia: an autoimmune disease? Eur J Gastroenterol Hepatol, 2003,15:447.

外科疾病导致的胆源性肝损伤诊治现状

Management of patients with biliary liver injury caused by surgical diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	姜浩, 张雯, 陈霞. 长效干扰素联合利巴韦林治疗慢性丙型肝炎患者疗效及其对静息能量消耗和营养状态的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 815-818.
[2]	黄飞虎, 薛建亚, 朱咏梅, 余姣, 王丽艳, 鲁琼. 应用索磷布韦/维帕他韦治疗门诊和住院筛查的丙型肝炎患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(6): 819-822.
[3]	肖金玉, 王延峰, 文小霞. 自身免疫性肝炎患者血清趋化因子CCL4和CXCL10水平及其临床意义探讨[J]. 实用肝脏病杂志, 2021, 24(6): 827-830.
[4]	杜云飞, 刘景瑞, 叶飞翔. N-乙酰半胱氨酸联合双环醇治疗抗结核药物所致的药物性肝损伤患者疗效研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 847-850.
[5]	刘玉玲, 甄增国, 王慧娟, 万秀敏, 郭振凯. 益生菌制剂对肝硬化并发自发性细菌性腹膜炎患者肠道屏障功能的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 867-870.
[6]	邢莉, 杜倩影, 姜艳丽, 韩冬. 分段注射对比剂CT增强扫描提高乙型肝炎肝硬化患者肝静脉显影效果研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 871-874.
[7]	黄力鸥, 吴春荣, 徐丹, 崔宇慧, 唐建国. 无肝素化连续性肾脏替代治疗肝硬化并发肝性脑病患者疗效研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 875-878.
[8]	王菁, 毕宁, 方亮, 田园. 自体骨髓干细胞经肝动脉肝内移植治疗失代偿期乙型肝炎肝硬化患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(6): 887-890.
[9]	束青华, 张楠楠, 葛勇胜. 不同HCV基因型感染的慢性丙型肝炎和肝硬化患者对重组人干扰素α-2a治疗应答的影响[J]. 实用肝脏病杂志, 2021, 24(6): 899-902.
[10]	吴慧娟, 何年安, 谢蠡, 叶显俊, 章生龙, 刘力. 超声造影联合血清CA19-9鉴别诊断胆管细胞癌与肝细胞癌应用研究[J]. 实用肝脏病杂志, 2021, 24(6): 903-906.
[11]	周正, 刘玮. 肝血管瘤、肝细胞癌和肝血管平滑肌脂肪瘤超声造影特点观察^*[J]. 实用肝脏病杂志, 2021, 24(6): 911-914.
[12]	俞士刚, 田佳, 吴铁, 樊书荣. 损伤控制性手术对创伤性肝破裂患者生存及相关应激指标的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 915-918.
[13]	蔡创, 范若英, 李伟, 吴胜, 田宇剑, 唐晓明, 金勇, 周城臣. 十二指肠乳头旁憩室对ERCP手术治疗胆总管结石患者效果的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 919-922.
[14]	梁晨, 郑素军. Wilson病治疗研究现状^*[J]. 实用肝脏病杂志, 2021, 24(6): 930-933.
[15]	李伟之, 李培杰, 马富权, 刘梦莹, 薛挥. 应用利伐沙班抗凝治疗经皮血管内介入治疗的布加综合征患者疗效和安全性研究^*[J]. 实用肝脏病杂志, 2021, 24(5): 621-624.